Growth Metrics

Eli Lilly (LLY) Cash from Operations (2016 - 2026)

Eli Lilly filings provide 18 years of Cash from Operations readings, the most recent being 5333000000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 220.11% to 5333000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 20480000000.0, a 119.79% increase, with the full-year FY2025 number at 16813000000.0, up 90.67% from a year prior.
  • Cash from Operations hit 5333000000.0 in Q1 2026 for Eli Lilly, up from 3224600000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 8835900000.0 in Q3 2025 to a low of 312000000.0 in Q4 2023.
  • Median Cash from Operations over the past 5 years was 2189500000.0 (2023), compared with a mean of 2517041176.47.
  • Biggest five-year swings in Cash from Operations: plummeted 118.76% in 2023 and later skyrocketed 892.92% in 2024.
  • Eli Lilly's Cash from Operations stood at 1662700000.0 in 2022, then crashed by 118.76% to 312000000.0 in 2023, then skyrocketed by 892.92% to 2473900000.0 in 2024, then surged by 30.34% to 3224600000.0 in 2025, then surged by 65.38% to 5333000000.0 in 2026.
  • The last three reported values for Cash from Operations were 5333000000.0 (Q1 2026), 3224600000.0 (Q4 2025), and 8835900000.0 (Q3 2025) per Business Quant data.